Biolinerx Ltd.

Biotechnology • Healthcare • Hevel Modi'in, Israel • BLRX (NCM)

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Wikipedia

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire

PR Newswire • Nov 24

BioLineRx stock rises after partner receives key patent allowance - Investing.com

Investing.com • Nov 19

$3.8B Market Opportunity: BioLineRx's Novel Brain Cancer Drug GLIX1 Targets DNA Damage in Glioblastoma - Stock Titan

Stock Titan • Sep 29

H.C. Wainwright Reaffirms Buy on BioLineRx Ltd. (BLRX) After ASCO 2025 - Yahoo Finance

Yahoo Finance • Jul 2

BLRX Stock Analysis and Forecast - Cash Flow Trends & Free Proven Portfolio Growth Strategies - earlytimes.in

earlytimes.in • Jan 3

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has BioLineRx Ltd. had layoffs?

No layoff events have been recorded for BioLineRx Ltd. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does BioLineRx Ltd. have?

BioLineRx Ltd. has approximately 28 employees.

What industry is BioLineRx Ltd. in?

BioLineRx Ltd. operates in the Biotechnology industry, within the Healthcare sector.

Is BioLineRx Ltd. a publicly traded company?

Yes, BioLineRx Ltd. is publicly traded under the ticker symbol BLRX on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is BioLineRx Ltd. headquartered?

BioLineRx Ltd. is headquartered in Hevel Modi'in, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.